Abnormal lung function in adults with congenital heart disease: Prevalence, relation to cardiac anatomy, and association with survival

Circulation

Volumn 127, Issue 8, 2013, Pages 882-890

  Alonso Gonzalez, Rafael ^a   Borgia, Francesco ^a   Diller, Gerhard Paul ^a,b   Inuzuka, Ryo ^a   Kempny, Aleksander ^a   Martinez Naharro, Ana ^a   Tutarel, Oktay ^a   Marino, Philip ^a   Wustmann, Kerstin ^a   Charalambides, Menelaos ^a   Silva, Margarida ^a   Swan, Lorna ^a   Dimopoulos, Konstantinos ^a,b   Gatzoulis, Michael A ^a,b  

^a ROYAL BROMPTON HOSPITAL   (United Kingdom)

^b NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

Author keywords

adult; heart diseases; lung; scoliosis; surgery; survival

Indexed keywords

ADULT; ARTICLE; BODY MASS; CARDIOVASCULAR MORTALITY; COHORT ANALYSIS; CONGENITAL HEART DISEASE; CONTROLLED STUDY; DIAPHRAGM PARALYSIS; DISEASE SEVERITY; FOLLOW UP; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; HUMAN; LUNG FUNCTION TEST; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; PREVALENCE; PRIORITY JOURNAL; SCOLIOSIS; SURVIVAL PREDICTION; THORACOTOMY;

ADULT; COHORT STUDIES; FEMALE; FOLLOW-UP STUDIES; HEART; HEART DEFECTS, CONGENITAL; HUMANS; LUNG DISEASES; MALE; MIDDLE AGED; PREVALENCE; RESPIRATORY FUNCTION TESTS; SURVIVAL RATE; VITAL CAPACITY; YOUNG ADULT;

EID: 84874492489     PISSN: 00097322     EISSN: 15244539     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.112.126755     Document Type: Article

References (43)

1. Poole-Wilson PA. The origin of symptoms in patients with chronic heart failure. Eur Heart J. 1988;9(suppl H):49-53.
2. Mancini DM, Henson D, LaManca J, Levine S. Respiratory muscle function and dyspnea in patients with chronic congestive heart failure. Circulation. 1992;86:909-918.
3. Warnes CA, Williams RG, Bashore TM, Child JS, Connolly HM, Dearani JA, del Nido P, Fasules JW, Graham TP Jr, Hijazi ZM, Hunt SA, King ME, Landzberg MJ, Miner PD, Radford MJ, Walsh EP, Webb GD. ACC/ AHA 2008 guidelines for the management of adults with congenital heart disease: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Develop Guidelines on the Management of Adults With Congenital Heart Disease). Circulation. 2008;118:e714-e833.
4. Niset G, Ninane V, Antoine M, Yernault JC. Respiratory dysfunction in congestive heart failure: Correction after heart transplantation. Eur Respir J. 1993;6:1197-1201.
5. Wright RS, Levine MS, Bellamy PE, Simmons MS, Batra P, Stevenson LW, Walden JA, Laks H, Tashkin DP. Ventilatory and diffusion abnormalities in potential heart transplant recipients. Chest. 1990;98:816-820.
6. Iversen KK, Kjaergaard J, Akkan D, Kober L, Torp-Pedersen C, Hassager C, Vestbo J, Kjoller E; ECHOS Lung Function Study Group. The prognostic importance of lung function in patients admitted with heart failure. Eur J Heart Fail. 2010;12:685-691.
7. Engström G, Lind P, Hedblad B, Wollmer P, Stavenow L, Janzon L, Lindgärde F. Lung function and cardiovascular risk: Relationship with inflammation-sensitive plasma proteins. Circulation. 2002;106:2555-2560.
8. Friedman GD, Klatsky AL, Siegelaub AB. Lung function and risk of myocardial infarction and sudden cardiac death. N Engl J Med. 1976;294:1071-1075.
9. Bolger AP, Sharma R, Li W, Leenarts M, Kalra PR, Kemp M, Coats AJ, Anker SD, Gatzoulis MA. Neurohormonal activation and the chronic heart failure syndrome in adults with congenital heart disease. Circulation. 2002;106:92-99.
10. Fredriksen PM, Therrien J, Veldtman G, Ali Warsi M, Liu P, Thaulow E, Webb G. Aerobic capacity in adults with tetralogy of Fallot. Cardiol Young. 2002;12:554-559.
11. Fredriksen PM, Therrien J, Veldtman G, Warsi MA, Liu P, Siu S, Williams W, Granton J, Webb G. Lung function and aerobic capacity in adult patients following modified Fontan procedure. Heart. 2001;85:295-299.
12. Baumgartner H, Bonhoeffer P, De Groot NM, de Haan F, Deanfield JE, Galie N, Gatzoulis MA, Gohlke-Baerwolf C, Kaemmerer H, Kilner P, Meijboom F, Mulder BJ, Oechslin E, Oliver JM, Serraf A, Szatmari A, Thaulow E, Vouhe PR, Walma E; Task Force on the Management of Grown-up Congenital Heart Disease of the European Society of Cardiology (ESC); Association for European Paediatric Cardiology (AEPC); ESC Committee for Practice Guidelines (CPG). ESC guidelines for the management of grown-up congenital heart disease (new version 2010). Eur Heart J. 2010;31:2915-2957.
13. Nieminen HP, Jokinen EV, Sairanen HI. Causes of late deaths after pediatric cardiac surgery: A population-based study. J Am Coll Cardiol. 2007;50:1263-1271.
14. Quanjer P, Helms P, Bjure J, Gualtier C. Standardization of lung function tests in paediatrics. Eur Resp J. 1989;2:121S-264S.
15. Lung function testing: Selection of reference values and interpretative strategies: American Thoracic Society. Am Rev Respir Dis. 1991;144:1202-1218.
16. Negrini S, Grivas TB, Kotwicki T, Rigo M, Zaina F; International Society on Scoliosis Orthopaedic and Rehabilitation Treatment (SOSORT). Guidelines on "standards of management of idiopathic scoliosis with corrective braces in everyday clinics and in clinical research": SOSORT Consensus 2008. DOI: 10.1186/1748-7161-4-2. Scoliosis. 2009;4:2.
17. Dimopoulos K, Diller GP, Koltsida E, Pijuan-Domenech A, Papadopoulou SA, Babu-Narayan SV, Salukhe TV, Piepoli MF, Poole-Wilson PA, Best N, Francis DP, Gatzoulis MA. Prevalence, predictors, and prognostic value of renal dysfunction in adults with congenital heart disease. Circulation. 2008;117:2320-2328.
18. Griffith KA, Sherrill DL, Siegel EM, Manolio TA, Bonekat HW, Enright PL. Predictors of loss of lung function in the elderly: The Cardiovascular Health Study. Am J Respir Crit Care Med. 2001;163:61-68.
19. Watson RA, Pride NB. Postural changes in lung volumes and respiratory resistance in subjects with obesity. J Appl Physiol. 2005;98:512-517.
20. Gold DR, Wang X, Wypij D, Speizer FE, Ware JH, Dockery DW. Effects of cigarette smoking on lung function in adolescent boys and girls. N Engl J Med. 1996;335:931-937.
21. Taggart DP, el-Fiky M, Carter R, Bowman A, Wheatley DJ. Respiratory dysfunction after uncomplicated cardiopulmonary bypass. Ann Thorac Surg. 1993;56:1123-1128.
22. Jonsson H, Ivert T, Jonasson R, Wahlgren H, Holmgren A, Björk VO. Pulmonary function thirteen to twenty-six years after repair of tetralogy of Fallot. J Thorac Cardiovasc Surg. 1994;108:1002-1009.
23. Chenoweth DE, Cooper SW, Hugli TE, Stewart RW, Blackstone EH, Kirklin JW. Complement activation during cardiopulmonary bypass: Evidence for generation of C3a and C5a anaphylatoxins. N Engl J Med. 1981;304:497-503.
24. Kalfin RE, Engelman RM, Rousou JA, Flack JE 3rd, Deaton DW, Kreutzer DL, Das DK. Induction of interleukin-8 expression during cardiopulmonary bypass. Circulation. 1993;88(pt 2):II401-II406.
25. Ng CS, Wan S, Yim AP, Arifi AA. Pulmonary dysfunction after cardiac surgery. Chest. 2002;121:1269-1277.
26. Gessler P, Pfenninger J, Pfammatter JP, Carrel T, Baenziger O, Dahinden C. Plasma levels of interleukin-8 and expression of interleukin-8 receptors on circulating neutrophils and monocytes after cardiopulmonary bypass in children. J Thorac Cardiovasc Surg. 2003;126:718-725.
27. McGowan FX Jr, Ikegami M, del Nido PJ, Motoyama EK, Kurland G, Davis PJ, Siewers RD. Cardiopulmonary bypass significantly reduces surfactant activity in children. J Thorac Cardiovasc Surg. 1993;106:968-977.
28. von Ungern-Sternberg BS, Petak F, Saudan S, Pellegrini M, Erb TO, Habre W; Swiss Paediatric Respiratory Research Group. Effect of cardiopulmonary bypass and aortic clamping on functional residual capacity and ventilation distribution in children. J Thorac Cardiovasc Surg. 2007;134:1193-1198.
29. Joho-Arreola AL, Bauersfeld U, Stauffer UG, Baenziger O, Bernet V. Incidence and treatment of diaphragmatic paralysis after cardiac surgery in children. Eur J Cardiothorac Surg. 2005;27:53-57.
30. Mok Q, Ross-Russell R, Mulvey D, Green M, Shinebourne EA. Phrenic nerve injury in infants and children undergoing cardiac surgery. Br Heart J. 1991;65:287-292.
31. Day GA, Upadhyay SS, Ho EK, Leong JC, Ip M. Pulmonary functions in congenital scoliosis. Spine. 1994;19:1027-1031.
32. Jones RS, Kennedy JD, Hasham F, Owen R, Taylor JF. Mechanical inefficiency of the thoracic cage in scoliosis. Thorax. 1981;36:456-461.
33. Redding G, Song K, Inscore S, Effmann E, Campbell R. Lung function asymmetry in children with congenital and infantile scoliosis. Spine J. 2008;8:639-644.
34. Weber B, Smith JP, Briscoe WA, Friedman SA, King TK. Pulmonary function in asymptomatic adolescents with idiopathic scoliosis. Am Rev Respir Dis. 1975;111:389-397.
35. Berend N, Marlin GE. Arrest of alveolar multiplication in kyphoscoliosis. Pathology. 1979;11:485-491.
36. Daganou M, Dimopoulou I, Alivizatos PA, Tzelepis GE. Pulmonary function and respiratory muscle strength in chronic heart failure: Comparison between ischaemic and idiopathic dilated cardiomyopathy. Heart. 1999;81:618-620.
37. Hammond MD, Bauer KA, Sharp JT, Rocha RD. Respiratory muscle strength in congestive heart failure. Chest. 1990;98:1091-1094.
38. Witt C, Borges AC, Haake H, Reindl I, Kleber FX, Baumann G. Respiratory muscle weakness and normal ventilatory drive in dilative cardiomyopathy. Eur Heart J. 1997;18:1322-1328.
39. Schweigmann G, Gassner I, Maurer K. Imaging the neonatal heart: Essentials for the radiologist. Eur J Radiol. 2006;60:159-170.
40. Giannakoulas G, Dimopoulos K, Bolger AP, Tay EL, Inuzuka R, Bedard E, Davos C, Swan L, Gatzoulis MA. Usefulness of natriuretic peptide levels to predict mortality in adults with congenital heart disease. Am J Cardiol. 2010;105:869-873.
41. Jiang R, Burke GL, Enright PL, Newman AB, Margolis HG, Cushman M, Tracy RP, Wang Y, Kronmal RA, Barr RG. Inflammatory markers and longitudinal lung function decline in the elderly. Am J Epidemiol. 2008;168:602-610.
42. Scarlata S, Pedone C, Fimognari FL, Bellia V, Forastiere F, Incalzi RA. Restrictive pulmonary dysfunction at spirometry and mortality in the elderly. Respir Med. 2008;102:1349-1354.
43. Standardization of spirometry, 1994 update: American Thoracic Society. Am J Respir Crit Care Med. 1995;152:1107-1136.